Exogenous Ketone Supplementation in Females with Polycystic Ovary Syndrome
Exogenous Ketone Supplementation to Improve Cardiovascular Disease Risk Factors in Females with Polycystic Ovary Syndrome
Sponsor: McGill University
Listed as NCT06155708, this NA trial focuses on PCOS and remains actively recruiting participants. Sponsored by McGill University, it has been updated 5 times since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Sep 2025 — Present [monthly]
Recruiting NA
-
Feb 2025 — Sep 2025 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Sep 2024 — Feb 2025 [monthly]
Not Yet Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting NA
-
Jan 2024 — Jul 2024 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- McGill University
For direct contact, visit the study record on ClinicalTrials.gov .